Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1061]
News [1546]
Articles [90]
Editorials [10]
Conferences [133]
elearning [2]
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 3: Lung Cancer
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 3: Lung Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 2: GU Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 2: GU Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 1: Breast Cancer
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 1: Breast Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
30 Jan 2023
Latest in lung cancer genomic testing
Prof Sanjay Popat - The Royal Marsden, London, UK
Latest in lung cancer genomic testing ( Prof Sanjay Popat - The Royal Marsden, London, UK )
26 Jan 2023
T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable...
Dr Ian Krop - Yale Cancer Center, Connecticut, USA
T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1 ( Dr Ian Krop - Yale Cancer Center, Connecticut, USA )
23 Dec 2022
Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk...
Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA
Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML ( Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA )
22 Dec 2022
Breast cancer patients who interrupted endocrine therapy to pursue pregnancy...
Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain
Breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse short-term recurrence rates ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )
22 Dec 2022
Comment: POLAR gene profile can identify which patients can safely avoid...
Prof Christos Markopoulos- National and Kapodistrian University of Athens...
Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery ( Prof Christos Markopoulos- National and Kapodistrian University of Athens, Athens, Greece )
22 Dec 2022
Updates from TAILORx and RxPONDER: Implications for practice
Prof Christos Markopoulos and Dr Kevin Kalinsky
Updates from TAILORx and RxPONDER: Implications for practice ( Prof Christos Markopoulos and Dr Kevin Kalinsky )
21 Dec 2022
Maximising cancer treatment and research through omics, data sharing, and open...
Dr Simon Parker - Data protection co-ordinator at the German Human Genome...
Maximising cancer treatment and research through omics, data sharing, and open science ( Dr Simon Parker - Data protection co-ordinator at the German Human Genome-phenome Archive )
20 Dec 2022
Epidemiology, detection, and management of NAFLD: a Latin American perspective
Dr Nahum Mendez-Sanchez - National Autonomous University of Mexico, Mexico City...
Epidemiology, detection, and management of NAFLD: a Latin American perspective ( Dr Nahum Mendez-Sanchez - National Autonomous University of Mexico, Mexico City, Mexico )
20 Dec 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation